Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlocking greater value per program and ultimately accelerate access to new treatments for patients. 2025 CNBC Disruptor 50 2025 Fierce 15 Award 2024 Endpoints 11 Award
| Website | https://www.formation.bio/ |
| Revenue | $41.8 million |
| Employees | 189 (144 on RocketReach) |
| Founded | 2013 |
| Address | 16 E 34th Street Fl 10, New York, New York 10016, US |
| Industry | Biotechnology Research |
| Keywords | Drug Development, Biotechnology, Drug Discovery, Biotech, Pharmaceutical, Biopharma, Clinical Trials, Therapeutics, Clinical Research, Pharmaceutical Technology, Innovative Therapies, Clinical Stage, Technology Platform, Life Sciences, Precision Medicine, Drug Manufacturing, Medical Technology, Healthcare Technology |
| Competitors | Amgen, Twist Bioscience, Zymergen, Inc., Moderna Therapeutics, Benson Hill, Amyris, Arzeda, GreenLight Biosciences, Sestina Bio, LLC., Geno +40 more (view full list) |
Looking for a particular Formation Bio employee's phone or email?
The Formation Bio annual revenue was $41.8 million in 2026.
Benjamine Liu is the CEO and Co-founder at Formation Bio of Formation Bio.
144 people are employed at Formation Bio.
Formation Bio is based in New York, New York.